{"title":"Evaluation of the efficacy and safety of ramucirumab combined with nab-paclitaxel, lobaplatin, and S-1 in neoadjuvant and conversion therapy for advanced gastric cancer: A study protocol of prospective single-center, randomized controlled and open label clinical trial (RNPLS-01)","link":"https://www.sciencedirect.com/science/article/pii/S2405844024055166?dgcid=rss_sd_all","date":null,"content":"<p>Publication date: 30 April 2024</p><p><b>Source:</b> Heliyon, Volume 10, Issue 8</p><p>Author(s): Juan Wang, Guanghui Xu, Shushang Liu, Yuxuan Ma, Shu Wang, Mengbin Li, Yan Zhao, Haoyuan Wang, Yuhao Wang, Chaosheng Peng, Huade Huo, Haolin Li, Gang Ji, Jianjun Yang</p>","author":"","siteTitle":"ScienceDirect Publication: Heliyon","siteHash":"f7bd7e3f1869707615b3e54fb4ebc4eb7c817c729fd5ad33a7fd4ed65328d468","entryHash":"586ae2ac6a527ffe541b686138bf5536703e5016a0129af9ae905e3ea7d6b02b","category":"Interdisciplinary"}